Washington, D.C. (August 27, 2012)— For the first time in its history, the Pharmaceutical Research and Manufacturers of America (PhRMA) will bestow a Research and Hope Award to individuals from academia, the patient and caregiving community as well as the biopharmaceutical sector who have made significant contributions to the advancement of patient care and medical innovation in the U.S. Each year, the award will honor advancements made in a selected therapeutic area, with this year’s award dedicated to Alzheimer’s disease.
The Awards will be presented during a ceremony on September 12, 2012 at the Newseum in Washington, DC. PhRMA is proud to co-host the ceremony with the National Association for Homecare & Hospice, the Alzheimer’s Foundation of America and the National Alliance for Caregiving. Our media partners include Scrip, The Pink Sheet andPharmaceutical Technology magazine.
“The Research and Hope Award celebrates the evolution of research and progress made in the battle against such a complex and devastating disease. Despite the enormous challenges faced by biopharmaceutical scientists, the achievements we will recognize illustrate that hope is still very much alive,” said John J. Castellani, president and CEO, PhRMA. “This is also an opportunity to better recognize those individuals who have devoted their lives to helping patients suffering from Alzheimer's disease.”
The keynote speech will be delivered by Mark Shriver, a longtime advocate for Alzheimer’s research and for programs that support families and caregivers struggling with the disease.
The Research and Hope Award evolved from the former Discoverer’s Award, which was presented to biopharmaceutical researcher pioneers in the drug discovery process. The new Award was conceived to recognize the diverse and deserving participants in the larger scientific and patient care ecosystem for their role in helping further medical innovation in the U.S. and providing strong support systems for patients and family members most in need.
Awards will be given in the following categories:
- The Research and Hope Award for Academic Research in Alzheimer’s
- Presented to an individual or team from the academic community for outstanding research in the search for a cure or treatment for Alzheimer’s disease.
- The Research and Hope Award for Biopharmaceutical Industry Research in Alzheimer’s
- Presented to an individual or team from a biopharmaceutical company for outstanding research in the search for a cure or treatment for Alzheimer’s disease.
- The Research and Hope Award for Patient Engagement
- Presented to an individual or organization for outstanding efforts in support of patients/families affected by the disease, including but not limited to communications programs, training, financial assistance, disease awareness, etc.
- The Research & Hope Award for Volunteer Champion
- Presented to an individual who has significantly affected the lives of patients and/or home caregivers in a charitable or humanitarian way. The Volunteer Champion recognizes individuals and caregivers who give selflessly to help other in need.
Read more on The Catalyst: Research and Hope Award: Celebrating Research and Hope in Battle Against Alzheimer's
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $49.5 billion in 2011 in discovering and developing new medicines.
Find PhRMA Online:
- Website – http://www.phrma.org
- Facebook – www.facebook.com/PhRMA
- Blog – www.phrma.org/catalyst
- Twitter – www.Twitter.com/PhRMAand www.Twitter.com/PhRMApress
- YouTube – www.youtube.com/PhRMApress
For information on how innovative medicines save lives, visit: http://www.innovation.org
For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org
For information on ensuring the flow of medicines during public health emergencies, visit http://www.rxresponse.org